Clinicn Investigator, Assc Prf Cancer Center, Mass General Research Institute

Associate Physician Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

Associate Professor of Medicine Harvard Medical School

MD Boston University 2006

antibodies, monoclonal, humanized; antineoplastic agents; bone neoplasms; central nervous system neoplasms; drug resistance, multiple; endothelium, vascular; heart failure; myocytes, cardiac; nerve tissue proteins; neuregulin-1; osteosarcoma; palmitates; receptor, erbb-2; sarcoma; transplantation conditioning Dr. Cote is a medical oncologist with at the Massachusetts General Hospital Cancer Center in the Henri and Belinda Termeer Center for Targeted Therapies (Phase I), the Center for Sarcoma and Connective Tissue Oncology and the Stephan L. Harris Center for Chordoma. His primary research interest is in developing novel agents for connective tissue malignancies through translational studies and early phase clinical trials.